NCT05304988 Development and Validation of the EFT for Adolescents With Cancer
| NCT ID | NCT05304988 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2020-09-07 |
| Primary Completion | 2023-09-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2020-09-07 with a primary completion date of 2023-09-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is increasing evidence of interventions shown to be effective to promote physical activity in adolescents with cancer. Nevertheless, adolescents with cancer become physically inactive after the end of the interventions. These interventions emphasized heavily on interventionists' role to assess adolescents' physical fitness and prescribe exercises. After the intervention, the adolescents were unable to follow the previous exercise prescriptions due to their changing medical conditions. To promote physical activity sustainably, it is vital to develop a patient-based assessment tool to allow adolescents with cancer to self-assess their own appropriate levels of physical activity that they could perform. However, a review of literature indicates a lack of such a tool.
Eligibility Criteria
Inclusion Criteria: * Aged 13-18 * are diagnosed with cancer * are able to communicate in Cantonese and read Chinese Exclusion Criteria: Those with physical or cognitive impairments and learning problems, as identified from the medical records, were excluded. Also, those with medical advice that physical activity was not recommended or with detailed exercise prescriptions from physicians or physiotherapists during recruitment were excluded.
Contact & Investigator
Katherine Lam, PhD
PRINCIPAL INVESTIGATOR
The Hong Kong Polytechnic University
Frequently Asked Questions
Who can join the NCT05304988 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05304988 currently recruiting?
Yes, NCT05304988 is actively recruiting participants. Contact the research team at kwkatlam@polyu.edu.hk for enrollment information.
Where is the NCT05304988 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT05304988 clinical trial?
NCT05304988 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Katherine Lam, PhD at The Hong Kong Polytechnic University. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.